Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.93 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.65 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.54 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.54 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.54 |
| ▸ | APP | P05067 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29862161 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL29862371 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL29919697 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL29862065 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL466299 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL133926 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL23457944 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL8927957 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL17312322 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL250402 | 1.00 | MAOB (0.93) | MAOBMAPK1ALDH1A1LMNATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1472 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4728836-A1 | PEROVSKITE MATERIAL AND USES THEREOF | Victoria Link Limited (NZ) | 2026-04-22 | — | — | EP | claimed |
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | KARLSRUHER INSTITUT FUER TECH KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) | 2026-02-19 | — | — | US | claimed |
| WO-2025136243-A1 | MECHANOCHEMICAL SYNTHESIS OF HISTAMINE H1-RECEPTOR ANTAGONISTS | IHSAN DOGRAMACI BILKENT UNIVERSITESI (TR) | 2025-06-26 | — | — | WO | claimed |
| WO-2025137252-A1 | HIGH THROUGHPUT METHOD FOR SCREENING LIPID NANOPARTICLE EFFICACY AND CYTOTOXICITY | CZ BIOHUB SF, LLC (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250177885-A1 | COMPOSITION, SYSTEM AND METHOD FOR REMOVAL OF DETERGENTS FROM AQUEOUS SOLUTIONS | DNA GENOTEK INC. (CA) | 2025-06-05 | — | — | US | claimed |
| WO-2025082165-A1 | CELL VIABILITY TESTING METHOD, INDICATOR AND USE THEREOF | 重庆精准生物产业技术研究院有限公司 | 2025-04-24 | — | — | WO | claimed |
| US-12214299-B2 | Composition, system and method for removal of detergents from aqueous solutions | DNA GENOTEK INC. (CA) | 2025-02-04 | — | — | US | claimed |
| WO-2024258297-A1 | PEROVSKITE MATERIAL AND USES THEREOF | VICTORIA LINK LIMITED (NZ) | 2024-12-19 | — | — | WO | claimed |
| CN-118641654-B | Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone | 山东泰合医药科技有限公司 | 2024-12-17 | — | — | CN | claimed |
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | claimed |
| US-20020002121-A1 | Fluorescent grease and bearings having the same therein | MINEBEA CO., LTD. (JP) | 2002-01-03 | — | — | US | claimed |
| EP-0752997-B1 | NOVEL CATIONIC PHOSPHOLIPIDS FOR TRANSFECTION | UNIV NORTHWESTERN (US) | 1998-08-19 | — | — | EP | claimed |
| EP-0360618-B1 | LIGHT-SENSITIVE COMPOSITION | FUJI PHOTO FILM CO., LTD. (JP) | 1992-12-16 | — | — | EP | claimed |
| EP-0360618-A2 | Light-sensitive composition | FUJI PHOTO FILM CO., LTD. (JP) | 1990-03-28 | — | — | EP | claimed |
| US-4282337-A | Process for preparing graft polymers of α,α'-disubstituted-β-propiolactones on isobutylene-triene-copolymers | ANIC S.P.A. (IT) | 1981-08-04 | — | — | US | claimed |
| US-4250053-A | WITH FLUORESCENT COMPOUND | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-02-10 | — | — | US | claimed |
| US-4195990-A | PARA-LINKED POLYPHENYLS OR POLYARYL UNSATURATED COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1980-04-01 | — | — | US | claimed |
| US-4100334-A | SUBSTITUTED HEXATRIENES OR OCTATRIENES | SNAM PROGETTI S.P.A. (IT) | 1978-07-11 | — | — | US | claimed |
| US-4045220-A | ELECTROGRAPHY | EASTMAN KODAK COMPANY (US) | 1977-08-30 | — | — | US | claimed |
| US-3971952-A | Method of detecting abnormal behavior of mammalian cells | YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) | 1976-07-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | GOT1, RNMT, GNAO1 | MAOB 4443/4885MAPK1 2728/4885ALDH1A1 1536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.